BVS vs SHAK
BVS: Bioventus is an orthopedic medical technology company focused on pain relief and musculoskeletal treatment through hyaluronic acid viscosupplements, bone growth stimulators, and emerging surgical and regenerative medicine platforms. SHAK: Shake Shack is a global "fine casual" restaurant brand that elevates traditional American fast food with premium ingredients and a modern, experience-driven approach.
Side-by-side fundamentals
| Metric | BVS | SHAK | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $12.45 | $63.07 | |
| Market cap as of 2026-08-01 | $1.1B | $2.7B | |
| P/E as of 2026-08-01 | 38.66 | 66.00 | BVS lower |
| PEG as of 2026-08-01 | 3.20 | 0.26 | SHAK lower |
| Net margin as of 2026-08-01 | +4.9% | +2.8% | BVS higher |
| Gross margin as of 2026-08-01 | +68.7% | +48.0% | BVS higher |
| Operating margin as of 2026-08-01 | +9.9% | +3.8% | BVS higher |
| ROE as of 2026-08-01 | +16.3% | +8.0% | BVS higher |
| ROA as of 2026-08-01 | +4.2% | +2.2% | BVS higher |
| Debt / equity as of 2026-08-01 | 1.49 | 0.50 | SHAK lower |
| Revenue growth (YoY) as of 2026-08-01 | +1.5% | +16.2% | SHAK higher |
| Revenue CAGR (3y) SEC XBRL | +3.5% | +17.1% | SHAK higher |
| Beta as of 2026-08-01 | 0.67 | 1.68 | |
| 1-year return as of 2026-07-27 close | +89.5% | -55.2% | BVS higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.